# FDA 483 - University Of Virginia Health System - June 12, 2026

Source: https://www.keypedia.com/records/483/university-of-virginia-health-system/f7326444-3d40-4286-b3e8-ccc22c7312be

> FDA 483 for University Of Virginia Health System on June 12, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: University Of Virginia Health System
- Inspection Date: 2026-06-12
- Product Type: biologics
- Office Name: Baltimore District Office
- Summary: An FDA inspection of the University Of Virginia Health System's Transfusion Medicine Services identified a significant deficiency in their standard operating procedures. The firm failed to establish maximum out-of-storage times for refrigerated blood products during irradiation processing, potentially compromising product integrity due to temperature excursions. This lack of procedural control could render units unsuitable for transfusion.

## Related Officers

- [Charles D. Boison](https://www.keypedia.com/people/charles-d-boison/b128f4a3-c1b1-409f-9291-27deb111d1e5)

Company: https://www.keypedia.com/companies/university-of-virginia-health-system/2b33c807-0186-4b41-bb33-686b67e4c8bd

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa